{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:06:43Z","timestamp":1788883603631,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000295","name":"Epilepsy Research Institute UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"The Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103055","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:45:58Z","timestamp":1786376758000},"page":"103055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA-sensing plasmid system for dynamic control of functional ion channel expression"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5235-1476","authenticated-orcid":false,"given":"Joschua","family":"Geuter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2450-3178","authenticated-orcid":false,"given":"Thomas T.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7649-2836","authenticated-orcid":false,"given":"Jack","family":"Corke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naxi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9223-6541","authenticated-orcid":false,"given":"Jordan","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1541-5148","authenticated-orcid":false,"given":"Stephanie","family":"Schorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-5102","authenticated-orcid":false,"given":"Gareth","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103055_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neuroscience.2022.03.010","article-title":"Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches","volume":"490","author":"Morris","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtn.2026.103055_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial","volume":"20","author":"Day","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2026.103055_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrneurol.2014.43","article-title":"Gene therapy in epilepsy\u2014is it time for clinical trials?","volume":"10","author":"Kullmann","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2026.103055_bib4","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1523\/JNEUROSCI.1143-18.2019","article-title":"Epilepsy gene therapy using an engineered potassium channel","volume":"39","author":"Snowball","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.103055_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/humc.2018.081","article-title":"Long-Term Follow-Up of a Phase I\/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson\u2019s Disease","volume":"29","author":"Palfi","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtn.2026.103055_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.febslet.2015.05.004","article-title":"Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitability","volume":"589","author":"Snowball","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2026.103055_bib7","doi-asserted-by":"crossref","first-page":"10380","DOI":"10.1523\/JNEUROSCI.3863-06.2006","article-title":"Next-generation optical technologies for illuminating genetically targeted brain circuits","volume":"26","author":"Deisseroth","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.103055_bib8","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103055_bib9","doi-asserted-by":"crossref","first-page":"eaaw1567","DOI":"10.1126\/sciadv.aaw1567","article-title":"Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics","volume":"5","author":"Weston","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.103055_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.abq6656","article-title":"On-demand cell-autonomous gene therapy for brain circuit disorders","volume":"378","author":"Qiu","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103055_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103055_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, Biogenesis, Mechanism, and Function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103055_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target Recognition and Regulatory Functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103055_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2021.04.007","article-title":"Opportunities and challenges for microRNA-targeting therapeutics for epilepsy","volume":"42","author":"Morris","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtn.2026.103055_bib15","doi-asserted-by":"crossref","first-page":"15977","DOI":"10.1073\/pnas.1919313117","article-title":"A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsy","volume":"117","author":"Ven\u00f8","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103055_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105048","article-title":"Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy","volume":"144","author":"Brennan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2026.103055_bib17","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1007\/s13277-015-4727-x","article-title":"Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene","volume":"37","author":"Jian","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.omtn.2026.103055_bib18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1113\/JP283719","article-title":"MicroRNAs \u2013 small RNAs with a big influence on brain excitability","volume":"601","author":"Morris","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.omtn.2026.103055_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.celrep.2016.08.074","article-title":"MicroRNA-Mediated Downregulation of the Potassium Channel Kv4.2 Contributes to Seizure Onset","volume":"17","author":"Gross","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2026.103055_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216658120","article-title":"MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control","volume":"120","author":"Heiland","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omtn.2026.103055_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11910-018-0870-2","article-title":"Regulation of Ion Channels by MicroRNAs and the Implication for Epilepsy","volume":"18","author":"Gross","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.omtn.2026.103055_bib22","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1093\/nar\/gkt797","article-title":"RILES, a novel method for temporal analysis of the in vivo regulation of miRNA expression","volume":"41","author":"Ezzine","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103055_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jconrel.2020.08.028","article-title":"Intracellular trafficking and functional monitoring of miRNA delivery in glioblastoma using lipopolyplexes and the miRNA-ON RILES reporter system","volume":"327","author":"Simion","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.103055_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2007.09.031","article-title":"miRNAs Play a Tune","volume":"131","author":"Hobert","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103055_bib25","first-page":"451","article-title":"Limitations of animal epilepsy research models: Can epileptic human tissue provide translational benefit?","volume":"38","author":"Morris","year":"2021","journal-title":"ALTEX"},{"key":"10.1016\/j.omtn.2026.103055_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:08:33Z","timestamp":1788880113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312600226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S216225312600226X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103055","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-sensing plasmid system for dynamic control of functional ion channel expression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103055"}}